NextCure Stock (NASDAQ: NXTC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 233.001K |
Day Range | - - - |
52 Wk Range | 0.980 - 2.090 |
Market Cap | $54.132M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 0.43% |
Days to Cover | 1.8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NextCure (NASDAQ: NXTC) through any online brokerage.
Other companies in NextCure’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Curis (NASDAQ:CRIS), Cellectar Biosciences (NASDAQ:CLRB) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for NextCure (NASDAQ: NXTC) was reported by HC Wainwright & Co. on Friday, March 22, 2024. The analyst firm set a price target for 8.00 expecting NXTC to rise to within 12 months (a possible 312.37% upside). 6 analyst firms have reported ratings in the last year.
The stock price for NextCure (NASDAQ: NXTC) is $1.94 last updated March 26, 2024 at 8:07 AM EDT.
There are no upcoming dividends for NextCure.
NextCure’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for NextCure.
NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.